380 related articles for article (PubMed ID: 33796822)
1. Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy.
Yaman S; Chintapula U; Rodriguez E; Ramachandramoorthy H; Nguyen KT
Cancer Drug Resist; 2020; 3(4):879-911. PubMed ID: 33796822
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
[TBL] [Abstract][Full Text] [Related]
3. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review.
He Z; Zhang Y; Feng N
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110298. PubMed ID: 31753336
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
[TBL] [Abstract][Full Text] [Related]
5. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
Thierry B
Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for Anticancer Drug Targeting: Recent Trends and Challenges.
Dahiya S; Dahiya R; Hernández E
Crit Rev Ther Drug Carrier Syst; 2021; 38(6):49-103. PubMed ID: 34587429
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
10. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
11. The development of site-specific drug delivery nanocarriers based on receptor mediation.
Wang X; Li S; Shi Y; Chuan X; Li J; Zhong T; Zhang H; Dai W; He B; Zhang Q
J Control Release; 2014 Nov; 193():139-53. PubMed ID: 24862317
[TBL] [Abstract][Full Text] [Related]
12. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
[TBL] [Abstract][Full Text] [Related]
13. Advances and Implications in Nanotechnology for Lung Cancer Management.
Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
[TBL] [Abstract][Full Text] [Related]
14. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
Jain AK; Das M; Swarnakar NK; Jain S
Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle hardness controls the internalization pathway for drug delivery.
Li Y; Zhang X; Cao D
Nanoscale; 2015 Feb; 7(6):2758-69. PubMed ID: 25585060
[TBL] [Abstract][Full Text] [Related]
17. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
Gopalan D; Pandey A; Udupa N; Mutalik S
J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
[TBL] [Abstract][Full Text] [Related]
18. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting.
Mendanha D; Vieira de Castro J; Ferreira H; Neves NM
J Control Release; 2021 Sep; 337():482-493. PubMed ID: 34352316
[TBL] [Abstract][Full Text] [Related]
20. Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.
Yu B; Xue X; Yin Z; Cao L; Li M; Huang J
Front Cell Dev Biol; 2022; 10():844050. PubMed ID: 35295856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]